Spero therapeutics to provide business update and report third quarter 2021 financial results on wednesday, november 10, 2021

Cambridge, mass., nov. 03, 2021 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that it will host a conference call and live audio webcast on wednesday, november 10, 2021, at 4:30 p.m. et to report its third quarter 2021 financial results and provide an update on its business and pipeline.
SPRO Ratings Summary
SPRO Quant Ranking